152 related articles for article (PubMed ID: 30390725)
21. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
22. Adverse cutaneous drug reactions--a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India.
Qayoom S; Bisati S; Manzoor S; Sameem F; Khan K
Arch Iran Med; 2015 Apr; 18(4):228-33. PubMed ID: 25841943
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability.
Tripathy R; Pattnaik KP; Dehury S; Patro S; Mohanty P; Sahoo SS; Mohanty S
Indian J Pharmacol; 2018; 50(4):192-196. PubMed ID: 30505055
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of cutaneous adverse drug reactions in Southwest China: an 11-year retrospective survey on in-patients of a dermatology ward.
Zhong H; Zhou Z; Wang H; Niu J; Chen W; Song Z; Hao F
Dermatitis; 2012; 23(2):81-5. PubMed ID: 22653124
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in adverse drug reactions in dermatological patients in west Sicily: an epidemiological study.
Pistone G; Gurreri R; Alaimo R; Curiale S; Bongiorno MR
J Dermatolog Treat; 2014 Dec; 25(6):510-2. PubMed ID: 23763287
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
Sushma M; Noel MV; Ritika MC; James J; Guido S
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphism of cytochrome P450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions.
Lee AY; Kim MJ; Chey WY; Choi J; Kim BG
Eur J Clin Pharmacol; 2004 May; 60(3):155-9. PubMed ID: 15024534
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Clinical Spectrum of Cutaneous Adverse Drug Reactions in Patients Presenting at a Tertiary Care Hospital in Pakistan.
Hina A; Masood S; Jamil S; Tabassum S; Jalil P; Ghulam U
Cureus; 2021 Apr; 13(4):e14568. PubMed ID: 34026384
[TBL] [Abstract][Full Text] [Related]
31. NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions.
Schlapbach C; Zawodniak A; Irla N; Adam J; Hunger RE; Yerly D; Pichler WJ; Yawalkar N
Allergy; 2011 Nov; 66(11):1469-76. PubMed ID: 21819408
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.
Chua KY; Tey KE
Int J STD AIDS; 2022 Aug; 33(9):812-820. PubMed ID: 35775121
[TBL] [Abstract][Full Text] [Related]
33. Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients.
Zheng L; Jin HB; Guan YY; Yang J
BMC Pharmacol Toxicol; 2022 Aug; 23(1):62. PubMed ID: 35948985
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.
Nandha R; Gupta A; Hashmi A
Int J Appl Basic Med Res; 2011 Jan; 1(1):50-3. PubMed ID: 23776774
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment.
Kim TO; Shin HJ; Kim YI; Lim SC; Koh YI; Kwon YS
Korean J Intern Med; 2019 Sep; 34(5):1050-1057. PubMed ID: 30879290
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.
Lehloenya RJ; Todd G; Wallace J; Ngwanya MR; Muloiwa R; Dheda K
Br J Dermatol; 2016 Jul; 175(1):150-6. PubMed ID: 26918554
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous adverse drug reactions in children. A series of 90 cases.
Khaled A; Kharfi M; Ben Hamida M; El Fekih N; El Aidli S; Zeglaoui F; Ezzine N; Fazaa B; Kamoun MR
Tunis Med; 2012 Jan; 90(1):45-50. PubMed ID: 22311448
[TBL] [Abstract][Full Text] [Related]
38. A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India.
Rana S; Gupta K; Agarwal N; Ahamed ANM
Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759420
[TBL] [Abstract][Full Text] [Related]
39. Oral Antifungal Therapy: Emerging Culprits of Cutaneous Adverse Drug Reactions.
Chaudhary RG; Rathod SP; Jagati A; Zankat D; Brar AK; Mahadevia B
Indian Dermatol Online J; 2019; 10(2):125-130. PubMed ID: 30984585
[TBL] [Abstract][Full Text] [Related]
40. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
Sharma R; Dogra D; Dogra N
Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
